These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Physical stress as a model to study variations in ADAMTS-13 activity, von Willebrand factor level and platelet activation. Claus RA; Bockmeyer CL; Sossdorf M; Lösche W; Hilberg T J Thromb Haemost; 2006 Apr; 4(4):902-5. PubMed ID: 16634765 [No Abstract] [Full Text] [Related]
12. Acute activation of the endothelium results in increased levels of active von Willebrand factor in hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome. Hulstein JJ; van Runnard Heimel PJ; Franx A; Lenting PJ; Bruinse HW; Silence K; de Groot PG; Fijnheer R J Thromb Haemost; 2006 Dec; 4(12):2569-75. PubMed ID: 16968329 [TBL] [Abstract][Full Text] [Related]
13. Magnesium maintains endothelial integrity, up-regulates proteolysis of ultra-large von Willebrand factor, and reduces platelet aggregation under flow conditions. Dong JF; Cruz MA; Aboulfatova K; Martin C; Choi H; Bergeron AL; Martini SR; Kroll MH; Kent TA Thromb Haemost; 2008 Mar; 99(3):586-93. PubMed ID: 18327408 [TBL] [Abstract][Full Text] [Related]
14. Disulfide bond reduction of von Willebrand factor by ADAMTS-13. Yeh HC; Zhou Z; Choi H; Tekeoglu S; May W; Wang C; Turner N; Scheiflinger F; Moake JL; Dong JF J Thromb Haemost; 2010 Dec; 8(12):2778-88. PubMed ID: 20946172 [TBL] [Abstract][Full Text] [Related]
15. Assembly and activation of alternative complement components on endothelial cell-anchored ultra-large von Willebrand factor links complement and hemostasis-thrombosis. Turner NA; Moake J PLoS One; 2013; 8(3):e59372. PubMed ID: 23555663 [TBL] [Abstract][Full Text] [Related]
16. P-selectin anchors newly released ultralarge von Willebrand factor multimers to the endothelial cell surface. Padilla A; Moake JL; Bernardo A; Ball C; Wang Y; Arya M; Nolasco L; Turner N; Berndt MC; Anvari B; López JA; Dong JF Blood; 2004 Mar; 103(6):2150-6. PubMed ID: 14630802 [TBL] [Abstract][Full Text] [Related]
17. Cleavage of von Willebrand factor by ADAMTS-13 on endothelial cells. López JA; Dong JF Semin Hematol; 2004 Jan; 41(1):15-23. PubMed ID: 14727255 [TBL] [Abstract][Full Text] [Related]
18. Effect of von Willebrand disease type 2B and type 2M mutations on the susceptibility of von Willebrand factor to ADAMTS-13. Rayes J; Hommais A; Legendre P; Tout H; Veyradier A; Obert B; Ribba AS; Girma JP J Thromb Haemost; 2007 Feb; 5(2):321-8. PubMed ID: 17087728 [TBL] [Abstract][Full Text] [Related]
19. von Willebrand factor, von Willebrand factor-cleaving protease, and shear stress. Perutelli P; Molinari AC Cardiovasc Hematol Agents Med Chem; 2007 Oct; 5(4):305-10. PubMed ID: 17979694 [TBL] [Abstract][Full Text] [Related]
20. Cleavage of ultralarge multimers of von Willebrand factor by C-terminal-truncated mutants of ADAMTS-13 under flow. Tao Z; Wang Y; Choi H; Bernardo A; Nishio K; Sadler JE; López JA; Dong JF Blood; 2005 Jul; 106(1):141-3. PubMed ID: 15774619 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]